Hosted on MSN

Viking Therapeutics targets 2025 Phase 3 trials for VK2735 obesity program with promising results

CEO Brian Lian highlighted the company's progress in advancing its VK2735 obesity program, with Phase 3 trials for the subcutaneous formulation set to begin later in Q2 2025. Additionally, enrollment ...
NCAA

How the 12-team College Football Playoff will work: Teams, schedule, bids

The College Football Playoff will have a 12-team playoff bracket for the 2026-27 season, the third year of that size after expanding from the four-team format. Here's what you need to know about the ...